Skip to content
IBAGS
IBAGS
  • Home
  • Conferences
  • News
  • IBAGS Council
  • Lifetime Members
  • About
    • Bylaws
IBAGS
IBAGS
  • Conferences
  • IBAGS Council:
  • IBAGS Lifetime Members
  • International Basal Ganglia Society
  • News
  • WELCOME TO THE INTERNATIONAL BASAL GANGLIA SOCIETY (IBAGS)
  • XV IBAGS Meeting

IBAGS Council:

Officers

John Reynolds

President

    Louise Parr-Brownlie

    Secretary

      Yoland Smith

      Treasurer

        Raffaella Tonini

        President Elect

          Paola Bonsi

          Secretary Elect

            Angela Cenci Nilsson

            Past president

              Gilberto Fisone

              Past secretary

                Councillors

                Satomi Chiken

                  Jill R Crittenden

                   

                    Jonathan Rubin

                      Stephanie Cragg

                        Elaine Del Bel

                          Joshua Goldberg

                            Christelle Baunez

                              Ledia F. Hernandez

                                Maxime Assous

                                  Wolf-Julian Neumann

                                    Veronique Sgambato

                                      Nathalie Dehorter

                                        Copyright © 2025 IBAGS

                                        We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept All”, you consent to the use of ALL the cookies. However, you may visit "Cookie Settings" to provide a controlled consent.
                                        Cookie SettingsAccept All
                                        Manage consent

                                        Privacy Overview

                                        This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
                                        Necessary
                                        Always Enabled
                                        Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.
                                        CookieDurationDescription
                                        cookielawinfo-checkbox-analytics11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
                                        cookielawinfo-checkbox-functional11 monthsThe cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
                                        cookielawinfo-checkbox-necessary11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
                                        cookielawinfo-checkbox-others11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
                                        cookielawinfo-checkbox-performance11 monthsThis cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
                                        viewed_cookie_policy11 monthsThe cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
                                        Functional
                                        Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features.
                                        Performance
                                        Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.
                                        Analytics
                                        Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.
                                        Advertisement
                                        Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads.
                                        Others
                                        Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet.
                                        SAVE & ACCEPT
                                        John Reynolds
                                        President

                                        John Reynolds initially had careers in medical electronics and then clinical Medicine and then completed a PhD in Neuroscience at University of Otago. His focus is in vivo approaches to brain disorders, learning models and circuit connectivity using electrophysiological recording methods and behavioural analyses. His interests have been in synaptic plasticity recorded in single neurons in the basal ganglia and in the role of dopamine and acetylcholine in the whole animal. He has recently extended this work to translational approaches to Parkinson’s disease in rodent and sheep models and is developing advanced neurostimulation and drug delivery approaches for progressive translation to humans.

                                        Close
                                        Louise Parr-Brownlie
                                        Secretary

                                        Louise Parr-Brownlie (Ngāti Maniapoto me Te Arawa) was a postdoctoral fellow at the National Institutes of Health in the United States before joining the Department of Anatomy at the University of Otago in 2010. Louise is a neurophysiologist investigating how neuronal activity in the basal ganglia, motor thalamus and motor cortex controls movement, and characterising changes associated with Parkinson’s disease. Recently, she has investigated the utility of optogenetic stimulation applied to the motor thalamus to recover movements in parkinsonian models. Louise has also worked with bioengineers to develop an implantable light-based device for continuous brain stimulation over 6 months, which is commercially available.

                                        Close
                                        Yoland Smith
                                        Treasurer

                                        Our research program aims at elucidating the neuroplasticity of cortical and subcortical brain circuits associated with the development of parkinsonism in nonhuman primate models of Parkinson’s disease.

                                        Close
                                        Raffaella Tonini
                                        President Elect

                                        Raffaella Tonini leads the Neuromodulation of Cortical and Subcortical Circuits Lab, at the Italian Institute of Technology (IIT), Italy. Her research goal is to understand how the brain learns to cope with an ever-changing environment and to choose between different behavioral options. Within this context, her research team focuses on the role of neuromodulatory substances in shaping micro- and macro circuit interactions to ultimately report selective perceptual and motivational information over multiple timescales.

                                        Close
                                        Paola Bonsi
                                        Secretary Elect

                                        Paola Bonsi is a researcher at the Laboratory of Neurophysiology and Plasticity, IRCCS Santa Lucia Foundation. She received a Ph.D. in pharmacology and toxicology from Sapienza, Università di Roma, in 1997. She was a post-doc in pharmacology and toxicology at Istituto Superiore di Sanità (1997–1998) and a post-doc in neurophysiology at IRCCS Santa Lucia Foundation (2001–2005). Her research is focused on the pathophysiology of developmental and movement disorders involving the corticostriatal circuits of the brain, in particular Parkinson’s disease, dystonia, and autism spectrum disorders.

                                        Close
                                        Angela Cenci Nilsson
                                        Past President

                                        I am a Professor of Experimental Medical Research at Lund University. After studying Medicine and Neurology in Italy, I moved to Sweden to pursue basic and translational research on basal ganglia disorders (particularly on Parkinson’s disease). To this end, our group developed rodent models reproducing key features of human movement disorders and used these models to uncover basic disease mechanisms and therapeutic targets. I have commissions of trust at several national and international organisations that support translational research on Parkinson’s disease and related disorders.

                                        Close
                                        Gilberto Fisone
                                        Past Secretary

                                        We study molecular and signal transduction mechanisms underlying neurotransmission in the basal ganglia. During the last two decades we identified key molecular events involved in the effects of various classes of drugs, including addictive substances and antipsychotic medications. We are also studying signal transduction abnormalities linked to motor and psychiatric complications caused by prolonged administration of antiparkinsonian drugs. More recently, we developed models of Parkinson’s disease to study the molecular and network alterations at the basis of non-motor symptoms, which include cognitive and affective disorders.

                                        Close
                                        Satomi Chiken

                                         

                                        Satomi Chiken

                                        Close
                                        Jill R Crittenden

                                        I am a Scientific Advisor at MIT with a background in the molecular and anatomical bases of basal ganglia function and dysfunction. My areas of focus, with an eye to public outreach, now include basal ganglia disorders, addiction, brain-body interactions and neurotechnology.

                                        Close
                                        Jonathan Rubin

                                         

                                        Jonathan Rubin

                                        Close
                                        Stephanie Cragg

                                        My laboratory focuses on understanding dopamine neurotransmission in the brain, particularly within the basal ganglia. We seek to improve understanding of the mechanisms regulating dopamine transmission and their dysfunction in neurodegenerative and other brain disorders, particularly Parkinson’s disease and addictions, to gain insights into disease aetiology and therapeutic avenues. We are a founding group of the Oxford Parkinson’s Disease Centre (OPDC).

                                        Close
                                        Elaine Del Bel

                                        I am a Physiology Full Professor af the Department of Physiology at Dental School of Ribeirao Preto, University of São Paulo since 2013.  My interest is in unveiling new mechanisms involved in the pathophysiology of neurodegenerative and mental disorders such as Parkinson’s disease and schizophrenia. We for example have shown that cannabinoid system abnormalities could be associated with sensorimotor gating deficits observed in schizophrenic patients and that the nitric oxide synthase inhibitors (iNOS) and the antibiotic doxycycline prevents degeneration of dopamine neurons.

                                        Close
                                        Joshua Goldberg

                                        Our lab studies cellular and network physiology of basal gangalia and brain stem circuits in rodent models of movement disorders, with an emphasis in recent years on the pathophysiology of prodromal symptoms of PD. We combine slice electrophsyiolgy in conjunction with multphoton imaging and optogenetics, endoscopic imaging and mathemaical modeling.

                                        Close
                                        Christelle Baunez

                                        Dr. Christelle Baunez, is Directrice de Recherche at the CNRS, leader of the team ‘Basal Ganglia, Motivation and Reward’ (BAGAMORE) at the Institut de Neurosciences de la Timone (INT) in Marseille (France). During her PhD thesis in Marseille on behavioral studies of pharmacological interactions between glutamate and dopamine within the basal ganglia, she started to be interested in the subthalamic nucleus (STN) as a possible target for the treatment of Parkinson’s disease. During her post-doctoral internship at Cambridge University (UK) (supervised by Prof. T.W. Robbins), she focused on the involvement of the STN in non-motor functions. She revealed the involvement of STN in attention and control of inhibition. She got her permanent position at the CNRS in 1997 and pursued her research on the functions of the STN, developing deep brain stimulation in behaving rats. One of her major finding, published in Nature Neuroscience in 2005 and PNAS in 2010, was to show that STN lesion or DBS reduces motivation for cocaine, while increasing motivation for food, suggesting that STN DBS could be applied to treat addiction. The research in her team extends to non-human primate and parkinsonian patients and is mainly focused on motivation.

                                        She has published 69 articles in international journals and 8 book chapters. She has been invited to present her work at 102 international (71) and national (31) symposia. She has co-organized international meetings and symposia in international meetings. She has been awarded various international and national fundings and prizes. She has recently served as president of the scientific council of the Institute for Life sciences at the CNRS. She is Principal Editor for Psychopharmacology. She is member of the board of various international societies (EBPS, EWCBR, IBAGS) and is currently president of the scientific council of France Parkinson Association. She is very active at teaching and mentoring students at various levels. Has been part of many boards of grant reviews and PhD committees.

                                        Close
                                        Ledia F. Hernandez

                                        After completion of her Ph.D. in Neuroscience at UCM (Universidad Complutense de Madrid, Spain), Ledia received a Fulbright grant to pursue postdoctoral training in Ann Graybiel´s Lab at MIT, where she studied the role of striatal dopamine in learning and habitual behaviour. As an investigator in Spain, her research is focused on Parkinson’s Disease. She is currently testing a novel hypothesis for what might cause this disease: the continuous engagement of dopamine neurons in the substantia nigra pars compacta (SNc) in habitual behaviour as a significant stressor for this vulnerable neuronal group (Hernandez et al, TINS, 2019). She has received European (Marie Slodowska-Curie grant) and national funding to pursue her research.

                                        Toward a deeper understanding of the role of each striatal pathway in movement control and levodopa induced dyskinesias (LIDs), Ledia recently developed a new animal model using optogenetics to evoke “optodyskinesias” in normal and dopamine depleted states. Currently, she is developing strategies to prevent LIDs and deepen the knowledge behind the selective and early onset loss of dopaminergic neurons in the SNc.

                                        Close
                                        Maxime Assous

                                         

                                        Maxime Assous

                                        Close
                                        Wolf-Julian Neumann

                                        I am a clinician scientist (MD) at the Movement Disorders and Neuromodulation Unit at Charité Berlin. I have built an expertise in movement disorders, neurophysiology and deep brain stimulation. My strengths are the implementation of methods for multimodal and multidimensional data analysis for clinical neuroscience applications. My current work combines computational modelling, machine and deep learning, structural and functional connectomics (fMRI), invasive (LFP/ECoG) and non-invasive (EEG/MEG) neurophysiology, to develop the next-generation of intelligent clinical brain computer interfaces for patients with movement disorders.

                                        The challenge I am currently working on is to try and integrate insights from PD pathophyisology, basal ganglia function, dopamine and reinforcement learning into a holistic cortex – basal ganglia – circuit model.

                                        I am actively engaging in programs and activities that aim to improve the scientific landscapes in terms of openness, reproducibility, diversity, equity and inclusiveness.

                                        I am severely hearing impaired.

                                        Close
                                        Veronique Sgambato

                                        I am a tenured researcher at INSERM (National institute of Health and medical research) and team leader at CNRS (National Center for scientific research) in Bron, France. After studying neurosciences in France, Canada and United States, I came back to France to study Parkinson’s disease.  My research focuses on the pathophysiology of motor and non-motor symptoms of Parkinson’s disease, combining a clinical approach in patients and a preclinical approach in animals.

                                        Close
                                        Nathalie Dehorter

                                         

                                        Nathalie Dehorter

                                        Close